Detalles de la búsqueda
1.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 385(14): 1280-1291, 2021 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587385
2.
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
Clin Gastroenterol Hepatol
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38723981
3.
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses.
Clin Gastroenterol Hepatol
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040274
4.
P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study.
Am J Gastroenterol
; 116(Suppl 1): S8, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461950
5.
P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
Am J Gastroenterol
; 116(Suppl 1): S9, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461954
6.
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial.
Am J Gastroenterol
; 116(Suppl 1): S9, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461956
7.
P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis.
Am J Gastroenterol
; 116(Suppl 1): S9-S10, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461957
8.
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
J Crohns Colitis
; 18(2): 264-274, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651686
9.
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
J Crohns Colitis
; 15(7): 1120-1129, 2021 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33438008
10.
Pharmacokinetics of nelfinavir in subjects with hepatic impairment.
J Clin Pharmacol
; 46(11): 1241-9, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17050789
11.
Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversion.
AIDS Res Hum Retroviruses
; 19(3): 189-99, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12689411
12.
Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
J Travel Med
; 21(6): 369-76, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345982
13.
In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.
Antimicrob Agents Chemother
; 49(6): 2267-75, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15917520
Resultados
1 -
13
de 13
1
Próxima >
>>